The introduction of nicotinamide being a nicotine replacement in e-cigarette and smokeless solutions signifies a significant regulatory challenge with the FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is thought to work as a sedative at significant dosages6. The statements made by Nicotine River, ECBlend, along with other